Vanguard Group »

Cns Pharmaceuticals shares owned by Vanguard Group

Quarter-by-quarter ownership of Cns Pharmaceuticals (CNSP) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Cns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Cns Pharmaceuticals held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cns Pharmaceuticals by Vanguard Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $74k 58k 1.27
2023-09-30 $27k 24k 1.14
2023-06-30 $53k 24k 2.23